Resources
Phosphorex Presents Its Nanosuspension Formulation at CRS Meeting
Phosphorex Presents Its Nanosuspension Formulation at Controlled Release Society Annual Meeting
Phosphorex Expands Facilities
Phosphorex announced today the acquisition of new laboratory and office space in Hopkinton, MA to meet the increasing demand for its products and services.
Phosphorex Technologies Showcased at Partnership Opportunities in Drug Delivery (PODD)
AstraZeneca Highlights Collaboration with Phosphorex on use of Zetafinity® Technology to More Effectively Target Immune Cells
Pharma Talk Radio Podcast, Future Outlook for Novel Drug Delivery
Partnership Opportunities in Drug Delivery (PODD) conference explores the value of drug delivery technologies both to patients and pharma with a focus on the future direction of the field.
Phosphorex Technologies Highlighted at Nanomedicine and Drug Delivery Symposium (NanoDDS'19)
Matthew Wingate, Director of Process Development, Described how Phosphorex Accelerates Nanomedicine Development from Proof of Concept to Clinical Trials
Phosphorex CEO Dr. Bin Wu Nominated for 2019 Barry M. Portnoy Immigrant Entrepreneur Awards
The Immigrant Learning Center today announced the nominees for the 2019 Barry M. Portnoy Immigrant Entrepreneur Awards
Phosphorex at the 44th Controlled Release Society Annual Meeting and Exposition in Boston
Phosphorex, Inc., a leading drug delivery company, today announced its participation in the upcoming Annual Meeting and Exposition of the Controlled Release Society, to be held at the Boston Convention Center, Boston, Massachusetts
Phosphorex Names Julia Rashba-Step as Vice President, R&D and Alliance Management
Phosphorex, Inc., a privately held company focused on the development of drug delivery products and technologies, today announced it has named former Pfizer's Senior Director of Novel Delivery Technologies, Julia Rashba-Step, Ph.D., to the newly created post of Vice President, Research & Development